Overview

  • Product name

    UDP-glucose, Highly  P2Y14 agonist
  • Description

    Highly potent P2Y14 agonist
  • Alternative names

    • UDP-glc
    • Uridine 5'-diphosphoglucose
    • Uridine-diphosphate-glucose disodium salt
  • Biological description

    Highly potent, endogenous P2Y14 agonist (EC50 = 82 nM). Involved in modulation of gastric function. UDP also available (ab120383).
  • CAS Number

    28053-08-9
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Bassil AK  et al. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms. Am J Physiol Gastrointest Liver Physiol 296:G923-30 (2009). Read more (PubMed: 19164486) »
  • Fricks IP  et al. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems. J Pharmacol Exp Ther 330:162-8 (2009). Read more (PubMed: 19339661) »
  • Abbracchio MP  et al. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24:52-5 (2003). Read more (PubMed: 12559763) »

Customer reviews and Q&As

Question
Answer

Thank you for contacting us. I have heard back from the lab with the following information: "We can confirm that the UDP-glucose does contain small amounts of UDP as it is used in the synthesis of this compound. Based on the HPLC the level of UDP is approximately 0.5%." This seems to be unavoidable based on the production process. I hope this information is helpful to you. Please do not hesitate to contact us if you need any more advice or information.

Read More

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up